Search PubMed⌕ Search

Biomedical subjects

J T Powell

Publications and source records attributed to J T Powell.

140 records · Page 8Linked to original sources
PubMed1976

Multiple antibiotic resistance in clinical strains of Neisseria gonorrhoeae isolated in South Carolina.

Minimal inhibitory concentration (MIC) values for penicillin G, tetracycline, amoxicillin, and actinomycin D were determined for 81 strains of Neisseria gonorrhoeae isolated from patients attending public health clinics in the Piedmont region of South Carolina. Gonococcal isolates were also screened for highlevel resistance to streptomycin. Significant positive correlations (r >/= 0.45, P </= 0.01) were found between all possible pairs of the antibiotics penicillin G, tetracycline, and amoxicillin. The MIC values of actinomycin D showed no significant positive correlations with the MIC values of the other antibiotics. Gonococcal strains that were resistant to streptomycin tended to be resistant to penicillin G, tetracycline, and amoxicillin. Of the 81 isolates, 18.5% were multiply resistant to penicillin G, tetracycline, amoxicillin, and streptomycin. Spontaneous mutants with reduced antibiotic susceptibility, selected for decreased susceptibility to penicillin G, displayed small decreases in susceptibility to tetracycline, amoxicillin, and actinomycin D. Spontaneous mutants selected for decreased susceptibility to actinomycin D displayed small losses in susceptibility to penicillin G. The results show that multiple antibiotic resistance occurs in clinically isolated gonococcal strains in South Carolina. The results further suggest the presence of a common genetic mechanism determining antibiotic resistance in N. gonorrhoeae.

Anti-Bacterial Agents↗
PubMed1975

On the interaction of alpha-lactalbumin and galactosyltransferase during lactose synthesis.

The regulatory effect of alpha-lactalbumin in the lactose synthase system has been ascribed to its reversible association with a complex of galactosyltransferase with Mn2+ and UDP-galactose, prior to the binding of monosaccharides; the resulting complex has a higher affinity for various monosaccharides. Two steps in the postulated catalytic cycle have been investigated; UDP-galactose binding to enzyme-Mn2+ by equilibrium dialysis and alpha-lactalbumin binding to enzyme-Mn2+-UDP-galactose by sedimentation velocity and kinetics. There is a single binding site for UDP-galactose on the enzyme-Mn2+ complex, and the dissociation constant for UDP-galactose from enzyme-Mn2+-UDP-galactose was found to be 72 muM at 37 degrees. The formation of a complex between galactosyltransferase and alpha-lactalbumin in the presence of Mn2+ and UDP-galactose was observed as an increase in sedimentation coefficient of enzyme activity So20,w from 3.25 +/- 0.03 in the absence of alpha-lactalbumin to 4.22 +/- 0.03 at saturating concentrations of alpha-lactalbumin, a value closely similar to that of a cross-linked 1:1 complex of the proteins under the same conditions (4.35 +/- 0.03). No interaction was observed in the absence of substrates or with UDP-galactose and EDTA. From the ultracentrifuge data and steady state kinetics, dissociation constants for alpha-lactalbumin from the enzyme-Mn2+-UDP-galactose-alpha-lactalbumin complex were determined at several temperatures and salt concentrations. These showed good internal agreement. The free energy change delta G degrees for the association of the two proteins is calculated, and the results are discussed in relation to the nature of the interaction.

Animals↗
PubMed1974

Glycosyltransferases in the Golgi membranes of onion stem.

Cell fractions consisting largely of Golgi membranes were prepared from the meristematic region of the onion. Several enzyme activities were found to be localized in these fractions: inosine diphosphatase, galactosyltransferases and glucosyltransferases. The fractions catalysed the transfer of [(14)C]galactose from UDP-galactose to endogenous and cell-sap acceptors, to N-acetylglucosamine and to ovalbumin. In the presence of bovine alpha-lactalbumin, transfer to glucose (lactose synthesis) was catalysed. [(14)C]Glucose was transferred from UDP-glucose to endogenous and cell-sap acceptors, to cellobiose and to fructose (sucrose synthesis). All these activities were latent, being potentiated by detergents (Triton X-100 or sodium deoxycholate). The characteristics of some of these enzyme activities are described and their biological significance is discussed.

Carbon Radioisotopes↗
PubMedDate not supplied

Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial.

BACKGROUND: Endovascular aneurysm repair (EVAR) is a new technology to treat patients with abdominal aortic aneurysm (AAA) when the anatomy is suitable. Uncertainty exists about how endovascular repair compares with conventional open surgery. EVAR trial 1 was instigated to compare these treatments in patients judged fit for open AAA repair. METHODS: Between 1999 and 2003, 1082 elective (non-emergency) patients were randomised to receive either EVAR (n=543) or open AAA repair (n=539). Patients aged at least 60 years with aneurysms of diameter 5.5 cm or more, who were fit enough for open surgical repair (anaesthetically and medically well enough for the procedure), were recruited for the study at 41 British hospitals proficient in the EVAR technique. The primary outcome measure is all-cause mortality and these results will be released in 2005. The primary analysis presented here is operative mortality by intention to treat and a secondary analysis was done in per-protocol patients. FINDINGS: Patients (983 men, 99 women) had a mean age of 74 years (SD 6) and mean AAA diameter of 6.5 cm (SD 1). 1047 (97%) patients underwent AAA repair and 1008 (93%) received their allocated treatment. 30-day mortality in the EVAR group was 1.7% (9/531) versus 4.7% (24/516) in the open repair group (odds ratio 0.35 [95% CI 0.16-0.77], p=0.009). By per-protocol analysis, 30-day mortality for EVAR was 1.6% (8/512) versus 4.6% (23/496) for open repair (0.33 [0.15-0.74], p=0.007). Secondary interventions were more common in patients allocated EVAR (9.8% vs 5.8%, p=0.02). INTERPRETATION: In patients with large AAAs, treatment by EVAR reduced the 30-day operative mortality by two-thirds compared with open repair. Any change in clinical practice should await durability and longer term results.

Aged↗
PubMedDate not supplied

The natural history of abdominal aortic aneurysms and their risk of rupture.

The UK Small Aneurysm Trial has shown that ultrasound surveillance is a safe management option for patients with small abdominal aortic aneurysms (4.0 to 5.5 cm in diameter), with an annual rupture rate of only 1%. We investigated baseline risk factors associated with aneurysm rupture in the 1090 trial patients and an additional 1167 patients enrolled in the UK Small Aneurysm Study. In this cohort of 2257 patients there were 103 cases of aneurysm rupture. After 3 years the annual rate of rupture was 2.2% (95% CI 1.7 to 2.8). The risk of rupture was independently and significantly associated with female sex (p < 0.001), larger initial aneurysm diameter (p < 0.001), current smoking (p = 0.01) and higher mean blood pressure (p = 0.01). Age, body mass index, serum cholesterol concentration and ankle/brachial pressure index were not associated with an increased risk of aneurysm rupture. The most surprising finding was that women had a 3-fold higher risk of aneurysm rupture than men. Effective control of blood pressure and cessation of smoking are two simple measures that are likely to diminish the risk of aneurysm rupture and improve the cardiovascular health of patients with abdominal aortic aneurysm.

Aged↗
PubMedDate not supplied

Acute phase proteins in patients with abdominal aortic aneurysms.

Both stenosis and aneurysmal dilatation are associated with atherosclerosis of the distal aorta. As part of an investigation into factors predisposing to aneurysmal dilatation we compared the levels of acute phase proteins in patients with stenosing and aneurysmal disease. Increased levels of acute phase proteins were found in patients with abdominal aortic aneurysms compared with patients with stenosing aortic disease. In 20 aneurysm patients the C-reactive protein was 56 +/- 10 mg/l, alpha 1-proteinase inhibitor 2.5 +/- 0.13 g/l and ceruloplasmin 0.41 +/- 0.01 g/l. In 20 patients with stenosing aortic disease the C-reactive protein was 28 +/- 8 mg/l, alpha 1-proteinase inhibitor 1.65 +/- 0.11 g/l and ceruloplasmin 0.35 +/- 0.03 g/l. These results argue for the participation of an inflammatory process in the aortic wall in the pathogenesis of all aneurysms.

Acute-Phase Proteins↗